ArticleBioengineered2020

MiR-132 inhibits migration and invasion and increases chemosensitivity of cisplatin-resistant oral squamous cell carcinoma cells via targeting TGF-β1.

Liqiang Chen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.